Dowling‐Degos disease: a review

Dowling‐Degos disease is a rare autosomal dominant genodermatosis. It is characterized by acquired reticulate hyperpigmentation over the flexures, comedone‐like follicular papules, and pitted perioral scars that usually develop during adulthood. Mutations in genes affecting melanosome transfer, and melanocyte and keratinocyte differentiation have been implicated in the pathogenesis of this disease. These genes include KRT5, POFUT1, POGLUT1 and, most recently, PSENEN. Dowling‐Degos disease can be found in isolation or with other associated findings, most notably hidradenitis suppurativa. This condition belongs to a spectrum of conditions that all result in reticulate hyperpigmentation that at times are hard to distinguish from each other. The most closely linked entity is Galli‐Galli, which is clinically indistinguishable from Dowling‐Degos disease and can only be distinguished by the presence of acantholysis on microscopy. Unfortunately, Dowling‐Degos disease is generally progressive and recalcitrant to treatment.

[1]  Lihua Zeng,et al.  Scrotal Dowling–Degos disease caused by a novel frameshift variant in gamma‐secretase subunit presenile enhancer gene , 2020, The Australasian journal of dermatology.

[2]  K. Peris,et al.  Novel nicastrin mutation in hidradenitis suppurativa–Dowling–Degos disease clinical phenotype: more than just clinical overlap? , 2020, The British journal of dermatology.

[3]  R. Betz,et al.  Mast cell activation in Dowling–Degos disease , 2019, The British journal of dermatology.

[4]  J. Simon,et al.  Full ablative versus fractional ablative laser therapy for Dowling–Degos disease , 2018, Lasers in surgery and medicine.

[5]  I. Betlloch,et al.  Novel POFUT1 mutation associated with hidradenitis suppurativa–Dowling–Degos disease firm up a role for Notch signalling in the pathogenesis of this disorder , 2018, The British journal of dermatology.

[6]  O. Sarig,et al.  A phenotype combining hidradenitis suppurativa with Dowling–Degos disease caused by a founder mutation in PSENEN , 2018, The British journal of dermatology.

[7]  Piyush Kumar,et al.  Generalized Dowling–Degos disease with hypopigmented lesions: A diagnostic challenge , 2018, Indian journal of dermatology, venereology and leprology.

[8]  V. Kharkar,et al.  Follicular Dowling–Degos Disease: A Rare Pigmentary Dermatosis , 2017, Indian dermatology online journal.

[9]  Maolan Li,et al.  Updated review of genetic reticulate pigmentary disorders , 2017, The British journal of dermatology.

[10]  A. Tafazzoli,et al.  Mutations in &ggr;-secretase subunit–encoding PSENEN underlie Dowling-Degos disease associated with acne inversa , 2017, The Journal of clinical investigation.

[11]  S. Tambe,et al.  Successful Management of Dowling-Degos Disease with Combination of Q-switched Nd: YAG and Fractional Carbon Dioxide Laser , 2017, Journal of cutaneous and aesthetic surgery.

[12]  Juan Du,et al.  Novel Mutations in PSENEN Gene in Two Chinese Acne Inversa Families Manifested as Familial Multiple Comedones and Dowling-Degos Disease , 2016, Chinese medical journal.

[13]  M. Akiyama,et al.  Reticulate acropigmentation of Kitamura with a novel ADAM10 mutation: A case report , 2016, The Journal of dermatology.

[14]  K. Linos,et al.  Dowling–Degos disease co‐presenting with Darier disease , 2016, Clinical and experimental dermatology.

[15]  B. Nirmal,et al.  Dermatoscopic Features of Hyper and Hypopigmented Lesions of Dowling Degos Disease , 2016, Indian journal of dermatology.

[16]  D. Asati,et al.  Dowling–Degos disease with reticulate acropigmentation of Kitamura: Extended spectrum of a single entity , 2016, Indian dermatology online journal.

[17]  Aakriti Gupta,et al.  Successful treatment of Dowling‐Degos disease using intense pulsed light , 2015, The Australasian journal of dermatology.

[18]  Peter Nürnberg,et al.  Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause autosomal-dominant Dowling-Degos disease. , 2014, American journal of human genetics.

[19]  J. H. Kim,et al.  Treatment of Dowling-Degos disease with fractional Er:YAG laser , 2013, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[20]  S. Khandpur,et al.  Follicular Dowling Degos disease: a rare variant of an evolving dermatosis. , 2013, Indian journal of dermatology, venereology and leprology.

[21]  N. Noppakun,et al.  Generalized Dowling-Degos Disease: Case Reports , 2013, Annals of dermatology.

[22]  F. Hao,et al.  Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease. , 2013, American journal of human genetics.

[23]  O. Abbas,et al.  Lentigolike macules and erythematous plaques on trunk and extremities-quiz case. , 2012, Archives of dermatology.

[24]  A. Lazar,et al.  McKee's pathology of the skin: with clinical correlations , 2012 .

[25]  M. Mokni,et al.  [Extensive Dowling-Degos disease following long term PUVA therapy]. , 2012, Annales de dermatologie et de venereologie.

[26]  P. Lynch,et al.  Dowling-Degos disease involving the vulva and back: case report and review of the literature. , 2011, Dermatology online journal.

[27]  D. Mutasim,et al.  Dowling-Degos disease presenting as hypopigmented macules. , 2011, Journal of the American Academy of Dermatology.

[28]  W. Stolz,et al.  Unique brown star shape on dermatoscopy of generalized Dowling‐Degos disease , 2011, The Australasian journal of dermatology.

[29]  J. Kim,et al.  A case of dowling-degos disease on the vulva. , 2011, Annals of dermatology.

[30]  Raphael Kopan Faculty Opinions recommendation of Gamma-secretase gene mutations in familial acne inversa. , 2010 .

[31]  M. Nöthen,et al.  Systematic mutation screening of KRT5 supports the hypothesis that Galli–Galli disease is a variant of Dowling–Degos disease , 2010, The British journal of dermatology.

[32]  A. Batycka‐Baran,et al.  Dowling-Degos Disease: Case Report and Review of the Literature , 2010, Dermatology.

[33]  P. Bhagwat,et al.  Three cases of Dowling Degos disease in two families. , 2009, Indian journal of dermatology, venereology and leprology.

[34]  S. Marimuthu,et al.  Acanthosis nigricans , 2009, Archives of Disease in Childhood.

[35]  Yu-Hung Wu,et al.  Generalized Dowling-Degos disease. , 2007, Journal of the American Academy of Dermatology.

[36]  H. Kerl,et al.  The expanding spectrum of Galli-Galli disease. , 2007, Journal of the American Academy of Dermatology.

[37]  M. A. Martín,et al.  Atypical presentation of Dowling‐Degos disease , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[38]  Lin He,et al.  A gene locus responsible for reticulate pigmented anomaly of the flexures maps to chromosome 17p13.3. , 2006, The Journal of investigative dermatology.

[39]  T. Sudarsanam,et al.  Dowling–Degos disease, hidradenitis suppurativa and arthritis in mother and daughter , 2006, Clinical and experimental dermatology.

[40]  M. Nöthen,et al.  Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. , 2006, American journal of human genetics.

[41]  W. Loo,et al.  Hidradenitis suppurativa, Dowling–Degos and multiple epidermal cysts: a new follicular occlusion triad , 2004, Clinical and experimental dermatology.

[42]  A. Saraswat,et al.  Dowling–Degos disease with dyschromatosis universalis hereditaria‐like pigmentation in a family , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[43]  T. Bieber,et al.  Successful Treatment of Dowling–Degos Disease with Er:YAG Laser , 2002, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[44]  S. Kossard,et al.  Dowling–Degos disease——A heat aggravated variant , 2001, The Australasian journal of dermatology.

[45]  H. Tagami,et al.  Dowling-Degos disease affecting the vulva. , 2001, Acta dermato-venereologica.

[46]  F. V. D. van den Hoogen,et al.  Tripe Palms Preceding Squamous Cell Carcinoma of the Lung by 11 Months , 1999, Dermatology.

[47]  M. Davis,et al.  Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases. , 1999, Journal of the American Academy of Dermatology.

[48]  C. Commens,et al.  Hidradenitis suppurativa, Dowling Degos disease and perianal squamous cell carcinoma , 1997, The Australasian journal of dermatology.

[49]  M. G. Cook,et al.  Dowling Degos disease in association with multiple seborrhoeic warts , 1997, Clinical and experimental dermatology.

[50]  N. Fenske,et al.  Dowling-Degos disease, hidradenitis suppurativa, and multiple keratoacanthomas. A disorder that may be caused by a single underlying defect in pilosebaceous epithelial proliferation. , 1991, Journal of the American Academy of Dermatology.

[51]  W. Bergfeld,et al.  Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma. , 1990, Cutis.

[52]  T. Schwarz,et al.  [Dowling-Degos disease: unsuccessful therapeutic trial with retinoids]. , 1987, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[53]  H. Gammaz,et al.  Dowling Degos Disease. , 1986, Indian journal of dermatology, venereology and leprology.

[54]  J. Boyle,et al.  Reticulate pigmented anomaly of the flexures and seborrhoeic warts , 1985, Clinical and experimental dermatology.

[55]  J. Geiger,et al.  Ultrastructure of Early Pigmentary Changes in Dowling‐Degos' Disease * , 1980, Journal of cutaneous pathology.

[56]  K. Grice,et al.  Reticulate pigmented anomaly of the flexures. Dowing Degos disease, a new genodermatosis. , 1978, Archives of dermatology.

[57]  R. Degos,et al.  [Reticulated pigmentary dermatosis of the folds: relation to acanthosis nigricans]. , 1954, Annales de dermatologie et de syphiligraphie.